Published in J Clin Microbiol on June 01, 2004
Emergence of a new norovirus genotype II.4 variant associated with global outbreaks of gastroenteritis. J Clin Microbiol (2006) 2.97
Use of TaqMan real-time reverse transcription-PCR for rapid detection, quantification, and typing of norovirus. J Clin Microbiol (2006) 2.82
Identification of Genogroup I and Genogroup II broadly reactive epitopes on the norovirus capsid. J Virol (2005) 1.53
Norovirus. Clin Microbiol Rev (2015) 1.41
Detection of Norovirus genogroup I and II by multiplex real-time RT- PCR using a 3'-minor groove binder-DNA probe. BMC Infect Dis (2006) 1.28
Microbiologic methods utilized in the MAL-ED cohort study. Clin Infect Dis (2014) 1.20
Porcine enteric caliciviruses: genetic and antigenic relatedness to human caliciviruses, diagnosis and epidemiology. Vaccine (2006) 1.14
Persistent digestive disorders in the tropics: causative infectious pathogens and reference diagnostic tests. BMC Infect Dis (2013) 1.11
European multicenter evaluation of commercial enzyme immunoassays for detecting norovirus antigen in fecal samples. Clin Vaccine Immunol (2007) 1.11
Diagnostic accuracy and analytical sensitivity of IDEIA Norovirus assay for routine screening of human norovirus. J Clin Microbiol (2010) 1.11
Evaluation of a commercial enzyme immunoassay for detection of norovirus in outbreak specimens. Eur J Clin Microbiol Infect Dis (2005) 0.96
Nanobody binding to a conserved epitope promotes norovirus particle disassembly. J Virol (2014) 0.94
The dynamics of norovirus outbreak epidemics: recent insights. Int J Environ Res Public Health (2011) 0.92
Characterization of cross-reactive norovirus-specific monoclonal antibodies. Clin Vaccine Immunol (2014) 0.91
Detection of norovirus antigens from recombinant virus-like particles and stool samples by a commercial norovirus enzyme-linked immunosorbent assay kit. J Clin Microbiol (2006) 0.87
Bioluminescent enzyme immunoassay for the detection of norovirus capsid antigen. Clin Vaccine Immunol (2012) 0.79
Epidemiological and virological investigation of a Norovirus outbreak in a resort in Puglia, Italy. BMC Infect Dis (2007) 0.75
Identification and Characterization of Single-Chain Antibodies that Specifically Bind GI Noroviruses. PLoS One (2017) 0.75
Food-related illness and death in the United States. Emerg Infect Dis (1999) 39.22
Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J Virol (1992) 8.35
STAT1-dependent innate immunity to a Norwalk-like virus. Science (2003) 6.35
Epidemiologic and molecular trends of "Norwalk-like viruses" associated with outbreaks of gastroenteritis in the United States. J Infect Dis (2002) 4.88
Design and evaluation of a primer pair that detects both Norwalk- and Sapporo-like caliciviruses by RT-PCR. J Virol Methods (1999) 4.14
Identification of a distinct common strain of "Norwalk-like viruses" having a global distribution. J Infect Dis (1999) 3.88
Phylogenetic analysis of the complete genome of 18 Norwalk-like viruses. Virology (2002) 3.79
Detection and differentiation of antigenically distinct small round-structured viruses (Norwalk-like viruses) by reverse transcription-PCR and southern hybridization. J Clin Microbiol (1995) 3.69
Genetic classification of "Norwalk-like viruses.. J Infect Dis (2000) 3.25
Development and application of a capsid VP1 (region D) based reverse transcription PCR assay for genotyping of genogroup I and II noroviruses. J Virol Methods (2004) 2.76
Two epidemiologic patterns of norovirus outbreaks: surveillance in England and wales, 1992-2000. Emerg Infect Dis (2003) 2.50
Simultaneous detection and genotyping of "Norwalk-like viruses" by oligonucleotide array in a reverse line blot hybridization format. J Clin Microbiol (2000) 2.49
International collaborative study to compare reverse transcriptase PCR assays for detection and genotyping of noroviruses. J Clin Microbiol (2003) 2.23
Surveillance of viral gastroenteritis in Japan: pediatric cases and outbreak incidents. J Infect Dis (2000) 2.04
Antigenic mapping of the recombinant Norwalk virus capsid protein using monoclonal antibodies. Virology (1996) 2.01
Molecular characterization and expression of the capsid protein of a Norwalk-like virus recovered from a Desert Shield troop with gastroenteritis. Virology (1994) 1.80
Expression and self-assembly of Grimsby virus: antigenic distinction from Norwalk and Mexico viruses. Clin Diagn Lab Immunol (1999) 1.77
Capsid protein diversity among Norwalk-like viruses. Virus Genes (2000) 1.72
Evaluation of a commercial ELISA for detecting Norwalk-like virus antigen in faeces. J Clin Virol (2003) 1.65
Expression and self-assembly of norwalk virus capsid protein from venezuelan equine encephalitis virus replicons. J Virol (2002) 1.60
Western blot (immunoblot) assay of small, round-structured virus associated with an acute gastroenteritis outbreak in Tokyo. J Clin Microbiol (1989) 1.55
A waterborne outbreak of Norwalk-like virus among snowmobilers-Wyoming, 2001. J Infect Dis (2002) 1.54
Characterization of Toronto virus capsid protein expressed in baculovirus. Arch Virol (1996) 1.48
Cross-reactivity among several recombinant calicivirus virus-like particles (VLPs) with monoclonal antibodies obtained from mice immunized orally with one type of VLP. J Clin Microbiol (2002) 1.40
Characterization of capsid genes, expressed in the baculovirus system, of three new genetically distinct strains of "Norwalk-like viruses". J Clin Microbiol (2001) 1.37
Genetic classification of "Sapporo-like viruses". Arch Virol (2001) 1.36
Development of an ELISA to detect MX virus, a human calicivirus in the snow Mountain agent genogroup. J Gen Virol (1995) 1.27
The genome of hawaii virus and its relationship with other members of the caliciviridae. Virus Genes (2001) 1.14
A one-year study of foodborne illnesses in the municipality of Uppsala, Sweden. Emerg Infect Dis (2001) 1.13
Precise characterization of norovirus (Norwalk-like virus)-specific monoclonal antibodies with broad reactivity. J Clin Microbiol (2003) 1.08
Molecular cloning, expression, and antigenicity of Seto virus belonging to genogroup I Norwalk-like viruses. J Clin Microbiol (2000) 1.01
Monoclonal antibodies for detection of Norwalk virus antigen in stools. J Clin Microbiol (1995) 0.99
Serotype-specific antigen ELISA for detection of Chiba virus in stools. J Med Virol (2000) 0.98
Molecular cloning, expression, self-assembly, antigenicity, and seroepidemiology of a genogroup II norovirus isolated in France. J Clin Microbiol (2003) 0.93
Molecular epidemiology of 'Norwalk-like viruses' associated with gastroenteritis outbreaks in New Zealand. J Med Virol (2001) 0.92
Major change in the predominant type of "Norwalk-like viruses" in outbreaks of acute nonbacterial gastroenteritis in Osaka City, Japan, between April 1996 and March 1999. J Clin Microbiol (2000) 0.89
[Evaluation of Norwalk virus detection kit by enzyme immunoassay]. Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi (2002) 0.78
[Newly developed Norwalk-like viruses detection ELISA by combination with monoclonal antibodies and hyperimmune rabbit sera]. Nihon Rinsho (2002) 0.77
Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis (2003) 9.44
Grand challenges in global mental health. Nature (2011) 8.40
Grand challenges in chronic non-communicable diseases. Nature (2007) 7.86
Rotavirus and severe childhood diarrhea. Emerg Infect Dis (2006) 7.80
Norovirus classification and proposed strain nomenclature. Virology (2005) 7.69
Systematic literature review of role of noroviruses in sporadic gastroenteritis. Emerg Infect Dis (2008) 7.48
Epidemiologic and molecular trends of "Norwalk-like viruses" associated with outbreaks of gastroenteritis in the United States. J Infect Dis (2002) 4.88
Public health. Implementation science. Science (2007) 4.33
Global mortality associated with rotavirus disease among children in 2004. J Infect Dis (2009) 3.63
Molecular and epidemiologic trends of caliciviruses associated with outbreaks of acute gastroenteritis in the United States, 2000-2004. J Infect Dis (2005) 3.16
Public health. Developing health workforce capacity in Africa. Science (2010) 3.05
Outbreaks of acute gastroenteritis on cruise ships and on land: identification of a predominant circulating strain of norovirus--United States, 2002. J Infect Dis (2004) 2.88
Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs. J Infect Dis (2005) 2.82
Use of TaqMan real-time reverse transcription-PCR for rapid detection, quantification, and typing of norovirus. J Clin Microbiol (2006) 2.82
Cost-effectiveness and potential impact of rotavirus vaccination in the United States. Pediatrics (2007) 2.75
The Global Enteric Multicenter Study (GEMS) of diarrheal disease in infants and young children in developing countries: epidemiologic and clinical methods of the case/control study. Clin Infect Dis (2012) 2.70
Demographic variability, vaccination, and the spatiotemporal dynamics of rotavirus epidemics. Science (2009) 2.67
The promise of new rotavirus vaccines. N Engl J Med (2006) 2.58
Norovirus and foodborne disease, United States, 1991-2000. Emerg Infect Dis (2005) 2.57
Public health. A major environmental cause of death. Science (2011) 2.32
Oral rotavirus vaccines: how well will they work where they are needed most? J Infect Dis (2009) 2.12
Molecular epidemiology of genogroup II-genotype 4 noroviruses in the United States between 1994 and 2006. J Clin Microbiol (2009) 2.06
Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2006) 2.05
Reevaluation of epidemiological criteria for identifying outbreaks of acute gastroenteritis due to norovirus: United States, 1998-2000. Clin Infect Dis (2006) 2.05
Diagnostic microbiologic methods in the GEMS-1 case/control study. Clin Infect Dis (2012) 1.98
Rotavirus antigenemia in patients with acute gastroenteritis. J Infect Dis (2005) 1.89
Real-world impact of rotavirus vaccination. Pediatr Infect Dis J (2011) 1.89
The etiology of severe acute gastroenteritis among adults visiting emergency departments in the United States. J Infect Dis (2012) 1.89
United States rotavirus strain surveillance from 2005 to 2008: genotype prevalence before and after vaccine introduction. Pediatr Infect Dis J (2011) 1.83
The epidemiology of rotavirus diarrhea in Latin America. Anticipating rotavirus vaccines. Rev Panam Salud Publica (2004) 1.80
Inter- and intragenus structural variations in caliciviruses and their functional implications. J Virol (2004) 1.79
AMP-activated protein kinase alpha2 activity is not essential for contraction- and hyperosmolarity-induced glucose transport in skeletal muscle. J Biol Chem (2005) 1.76
Diarrhea- and rotavirus-associated hospitalizations among children less than 5 years of age: United States, 1997 and 2000. Pediatrics (2006) 1.64
The global burden of diarrhoeal disease in children. Bull World Health Organ (2003) 1.61
Scientific rationale for a change in the composition of oral rehydration solution. JAMA (2004) 1.57
A waterborne outbreak of Norwalk-like virus among snowmobilers-Wyoming, 2001. J Infect Dis (2002) 1.54
The role of serum antibodies in the protection against rotavirus disease: an overview. Clin Infect Dis (2002) 1.53
Multicenter, hospital-based surveillance of rotavirus disease and strains among indian children aged <5 years. J Infect Dis (2009) 1.49
Inhibitory effect of breast milk on infectivity of live oral rotavirus vaccines. Pediatr Infect Dis J (2010) 1.48
Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam. J Infect Dis (2005) 1.47
Perceived threats and real killers. Science (2004) 1.41
Human caliciviruses as a cause of severe gastroenteritis in Peruvian children. J Infect Dis (2004) 1.37
Are noroviruses emerging? Emerg Infect Dis (2005) 1.36
Foodborne viral gastroenteritis: challenges and opportunities. Clin Infect Dis (2002) 1.35
Hospitalizations associated with rotavirus gastroenteritis in the United States, 1993-2002. Pediatr Infect Dis J (2006) 1.35
Global impact of rotavirus vaccines. Expert Rev Vaccines (2010) 1.34
Widespread outbreak of norovirus gastroenteritis among evacuees of Hurricane Katrina residing in a large "megashelter" in Houston, Texas: lessons learned for prevention. Clin Infect Dis (2007) 1.34
Norovirus transmission on cruise ship. Emerg Infect Dis (2005) 1.33
Detection of viral agents in fecal specimens of monkeys with diarrhea. J Med Primatol (2007) 1.29
Diversity of rotavirus strains among children with acute diarrhea in China: 1998-2000 surveillance study. J Clin Microbiol (2002) 1.29
The global alliance for chronic diseases. Science (2009) 1.23
Sentinel hospital surveillance for rotavirus diarrhea in the People's Republic of China, August 2001-July 2003. J Infect Dis (2005) 1.22
Role of AMP-activated protein kinase in exercise capacity, whole body glucose homeostasis, and glucose transport in skeletal muscle -insight from analysis of a transgenic mouse model-. Diabetes Res Clin Pract (2007) 1.18
Differential profiles and inhibitory effect on rotavirus vaccines of nonantibody components in breast milk from mothers in developing and developed countries. Pediatr Infect Dis J (2013) 1.17
Use of active surveillance to validate international classification of diseases code estimates of rotavirus hospitalizations in children. Pediatrics (2005) 1.17
Rotavirus in Asia: the value of surveillance for informing decisions about the introduction of new vaccines. J Infect Dis (2005) 1.17
Inactivated rotavirus vaccines: a priority for accelerated vaccine development. Vaccine (2008) 1.17
Disease burden and risk factors for hospitalizations associated with rotavirus infection among children in New York State, 1989 through 2000. Pediatr Infect Dis J (2003) 1.15
The globalization of health research: harnessing the scientific diaspora. Acad Med (2009) 1.15
Inactivated rotavirus vaccine induces protective immunity in gnotobiotic piglets. Vaccine (2010) 1.14
Global health: the Fogarty International Center, National Institutes of Health: vision and mission, programs, and accomplishments. Infect Dis Clin North Am (2011) 1.14
Epidemiological profile and burden of rotavirus diarrhea in Vietnam: 5 years of sentinel hospital surveillance, 1998-2003. J Infect Dis (2005) 1.13
Assessment of the epidemic potential of a new strain of rotavirus associated with the novel G9 serotype which caused an outbreak in the United States for the first time in the 1995-1996 season. J Clin Microbiol (2004) 1.13
A systematic review of anti-rotavirus serum IgA antibody titer as a potential correlate of rotavirus vaccine efficacy. J Infect Dis (2013) 1.12
Outbreaks of adult gastroenteritis traced to a single genotype of rotavirus. J Infect Dis (2002) 1.11
The epidemiology and burden of rotavirus in China: a review of the literature from 1983 to 2005. Vaccine (2006) 1.11
The pathology of rotavirus-associated deaths, using new molecular diagnostics. Clin Infect Dis (2003) 1.10
Immunogenicity of a thermally inactivated rotavirus vaccine in mice. Hum Vaccin (2007) 1.08
Rotavirus vaccines--early success, remaining questions. N Engl J Med (2009) 1.07
G and P types of circulating rotavirus strains in the United States during 1996-2005: nine years of prevaccine data. J Infect Dis (2009) 1.07
Update on rotavirus vaccines. Pediatr Infect Dis J (2005) 1.06
Safety and immunogenicity of two live attenuated human rotavirus vaccine candidates, 116E and I321, in infants: results of a randomised controlled trial. Vaccine (2006) 1.05
Rotavirus vaccines and the prevention of hospital-acquired diarrhea in children. Vaccine (2004) 1.05
Rotavirus disease and its prevention. Curr Opin Gastroenterol (2005) 1.05
Astrovirus acute gastroenteritis among children in Madrid, Spain. Pediatr Infect Dis J (2002) 1.05
Rotavirus infection alters peripheral T-cell homeostasis in children with acute diarrhea. J Virol (2007) 1.05
Rotavirus strain surveillance in Latin America: a review of the last nine years. Pediatr Infect Dis J (2004) 1.04
Noroviruses as a cause of traveler's diarrhea among students from the United States visiting Mexico. J Clin Microbiol (2005) 1.03
Rotavirus: realising the potential of a promising vaccine. Lancet (2010) 1.02
Routine laboratory testing data for surveillance of rotavirus hospitalizations to evaluate the impact of vaccination. Pediatr Infect Dis J (2007) 1.02
Household air pollution in low- and middle-income countries: health risks and research priorities. PLoS Med (2013) 1.02
The expanding diversity of rotaviruses. Lancet (2002) 1.01
The epidemiology of rotavirus diarrhea in countries in the Eastern Mediterranean Region. J Infect Dis (2010) 1.01
Temporal and geographic trends of rotavirus activity in the United States, 1997-2004. Pediatr Infect Dis J (2006) 1.00
Detection and characterisation of human astroviruses in children with acute gastroenteritis in Blantyre, Malawi. J Med Virol (2002) 0.99
Prevalence of rotavirus and norovirus antibodies in non-human primates. J Med Primatol (2004) 0.99
Hospital-based study of the economic burden associated with rotavirus diarrhea in Hong Kong. J Infect Dis (2005) 0.98
Incidence of rotavirus diarrhea and intussusception in Hong Kong using standardized hospital discharge data. Pediatr Infect Dis J (2002) 0.98
Norovirus detection and genotyping for children with gastroenteritis, Brazil. Emerg Infect Dis (2007) 0.97
Estimates of rotavirus disease burden in Hong Kong: hospital-based surveillance. J Infect Dis (2005) 0.96
Importance and challenges of accurately counting rotavirus deaths in China, 2002. Vaccine (2009) 0.96
Quantitative evaluation of rotaviral antigenemia in children with acute rotaviral diarrhea. J Infect Dis (2006) 0.96
Serum IgG mediates mucosal immunity against rotavirus infection. Proc Natl Acad Sci U S A (2005) 0.95
Public health. Progress toward rotavirus vaccines. Science (2006) 0.95
Molecular characterization of human rotavirus vaccine strain CDC-9 during sequential passages in Vero cells. Hum Vaccin (2010) 0.94
Diarrhea-associated hospitalizations and outpatient visits among American Indian and Alaska Native children younger than five years of age, 2000-2004. Pediatr Infect Dis J (2007) 0.94